Acquiring Company
HAS Healthcare Advanced Synthesis SA
Acquired Company
Cerbios-Pharma SA
BiascaLuganoManufacturingHealth CareBiotechnologyDescription
HAS Healthcare Advanced Synthesis SA has successfully acquired Cerbios-Pharma SA. This acquisition aims to establish a leading international group in the CDMO sector. The initiative is supported by 65 Equity Partners, enhancing their market position and capabilities.
Quick answer
HAS Healthcare Advanced Synthesis SA is acquiring Cerbios-Pharma SA, announced March 31, 2025. HAS Healthcare Advanced Synthesis SA is based in Biasca, Ticino, Switzerland.
- How much did HAS Healthcare Advanced Synthesis SA pay for Cerbios-Pharma SA?
- The deal value was not disclosed.
- What does HAS Healthcare Advanced Synthesis SA do?
- HAS Healthcare Advanced Synthesis SA is a company focused on providing advanced synthesis solutions in the healthcare sector.
- Where are HAS Healthcare Advanced Synthesis SA and Cerbios-Pharma SA based?
- HAS Healthcare Advanced Synthesis SA is based in Biasca, Ticino, Switzerland. Cerbios-Pharma SA is based in Lugano, Ticino, Switzerland.
- Who are the decision-makers at HAS Healthcare Advanced Synthesis SA?
- Fundz holds 2 contacts at HAS Healthcare Advanced Synthesis SA. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Manufacturing and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel for $45 per share (April 15, 2025)
- AbbVie acquires Cerevel Therapeutics for $45 per share (March 31, 2025)
- Curium acquires Monrol to boost Lu-177 capacity (March 28, 2025)
- Roquette acquires IFF Pharma Solutions for growth (May 5, 2025)
- Hikma acquires ANDA for trametinib from Novugen (April 17, 2025)
- Granules India acquires Senn Chemicals AG (April 11, 2025)
Who to call at HAS Healthcare Advanced Synthesis SA, and when
When HAS Healthcare Advanced Synthesis SA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day HAS Healthcare Advanced Synthesis SA raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HAS Healthcare Advanced Synthesis SA, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HAS Healthcare Advanced Synthesis SA. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HAS Healthcare Advanced Synthesis SA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cerbios-Pharma SA?
Cerbios-Pharma SA was acquired by HAS Healthcare Advanced Synthesis SA, based in Biasca. The deal was reported on March 31, 2025. HAS Healthcare Advanced Synthesis SA is a company focused on providing advanced synthesis solutions in the healthcare sector. It specializes in Contract Development and Manufacturing Organization (CDMO) services. HAS Healthcare Advanced Synthesis SA is privately held and operates in Manufacturing.
When did HAS Healthcare Advanced Synthesis SA acquire Cerbios-Pharma SA?
HAS Healthcare Advanced Synthesis SA's acquisition of Cerbios-Pharma SA was reported on March 31, 2025. HAS Healthcare Advanced Synthesis SA has successfully acquired Cerbios-Pharma SA. This acquisition aims to establish a leading international group in the CDMO sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cerbios-Pharma SA do?
It is privately held, operating in Biotechnology, and is based in Lugano.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.